CalciMedica Director Alan Glicklich Receives 10,000-Share Award

What Happened
Alan Glicklich, a director of CalciMedica, Inc. (CALC), was granted a derivative award covering 10,000 shares on 2026-08-19. The award is reported at $0.00 per share (no cash purchase), so no cash value was paid at grant. This is an issuance/award to an insider (not a purchase or sale).

Key Details

• Transaction date: 2026-08-19; Form 4 filed 2026-08-21 (filed two days after the transaction).
• Transaction type/code: A — Grant/Award (derivative securities).
• Amount: 10,000 shares; reported price: $0.00.
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: Vesting is 1/12th of the shares monthly over one year after grant; the award will be fully vested by the 2027 annual meeting of stockholders.
• No indication of immediate exercise or sale in this filing.

Context
This is a director compensation award (derivative interest) rather than an open-market purchase or sale. For retail investors, such grants are common for board compensation and do not alone signal buying or selling intent. The footnote shows a monthly vesting schedule over one year, meaning the economic benefit is realized gradually unless earlier accelerated at the 2027 annual meeting.